Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1955 1
1957 1
1959 2
1960 2
1962 2
1963 4
1964 1
1965 3
1966 1
1967 1
1973 1
1974 1
1975 1
1977 1
1978 1
1979 1
1981 2
1982 4
1983 3
1984 6
1985 12
1986 11
1987 13
1988 13
1989 19
1990 23
1991 27
1992 20
1993 25
1994 26
1995 21
1996 19
1997 15
1998 30
1999 33
2000 31
2001 52
2002 51
2003 61
2004 84
2005 98
2006 92
2007 108
2008 119
2009 138
2010 149
2011 154
2012 168
2013 166
2014 169
2015 209
2016 197
2017 189
2018 189
2019 204
2020 238
2021 262
2022 294
2023 228
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

3,606 results

Results by year

Filters applied: . Clear all
Page 1
ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer.
Hsieh RC, Krishnan S, Wu RC, Boda AR, Liu A, Winkler M, Hsu WH, Lin SH, Hung MC, Chan LC, Bhanu KR, Srinivasamani A, De Azevedo RA, Chou YC, DePinho RA, Gubin M, Vilar E, Chen CH, Slay R, Jayaprakash P, Hegde SM, Hartley G, Lea ST, Prasad R, Morrow B, Couillault CA, Steiner M, Wang CC, Venkatesulu BP, Taniguchi C, Kim YSB, Chen J, Rudqvist NP, Curran MA. Hsieh RC, et al. Among authors: chou yc. Sci Immunol. 2022 Jun 10;7(72):eabl9330. doi: 10.1126/sciimmunol.abl9330. Epub 2022 Jun 10. Sci Immunol. 2022. PMID: 35687697 Free PMC article.
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.
Nanjo S, Wu W, Karachaliou N, Blakely CM, Suzuki J, Chou YT, Ali SM, Kerr DL, Olivas VR, Shue J, Rotow J, Mayekar MK, Haderk F, Chatterjee N, Urisman A, Yeo JC, Skanderup AJ, Tan AC, Tam WL, Arrieta O, Hosomichi K, Nishiyama A, Yano S, Kirichok Y, Tan DS, Rosell R, Okimoto RA, Bivona TG. Nanjo S, et al. Among authors: chou yt. J Clin Invest. 2022 Jul 1;132(13):e145099. doi: 10.1172/JCI145099. J Clin Invest. 2022. PMID: 35579943 Free PMC article.
Uremic Tumoral Calcinosis.
Chou YP, Hsieh YK, Wu CL. Chou YP, et al. J Nephrol. 2022 Dec;35(9):2443-2444. doi: 10.1007/s40620-022-01488-6. Epub 2022 Nov 1. J Nephrol. 2022. PMID: 36319937 No abstract available.
Fixed drug eruption.
Chou YJ, Chang HC. Chou YJ, et al. CMAJ. 2022 Aug 2;194(29):E1036. doi: 10.1503/cmaj.220049. CMAJ. 2022. PMID: 35918090 Free PMC article. No abstract available.
Integrated genomic analyses of hepatocellular carcinoma.
Chang YS, Tu SJ, Chen HD, Hsu MH, Chen YC, Chao DS, Chung CC, Chou YP, Chang CM, Lee YT, Yen JC, Jeng LB, Chang JG. Chang YS, et al. Among authors: chou yp. Hepatol Int. 2023 Feb;17(1):97-111. doi: 10.1007/s12072-022-10455-z. Epub 2022 Dec 6. Hepatol Int. 2023. PMID: 36472800
Ultrafast Polymer Dynamics through a Nanopore.
Lin CY, Fotis R, Xia Z, Kavetsky K, Chou YC, Niedzwiecki DJ, Biondi M, Thei F, Drndić M. Lin CY, et al. Among authors: chou yc. Nano Lett. 2022 Nov 9;22(21):8719-8727. doi: 10.1021/acs.nanolett.2c03546. Epub 2022 Oct 31. Nano Lett. 2022. PMID: 36315497
3,606 results